Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Adverse effects of supplemental L-arginine in atherosclerosis: consequences of methylation stress in a complex catabolism?

Loscalzo J.

Arterioscler Thromb Vasc Biol. 2003 Jan 1;23(1):3-5. No abstract available.

2.

Effects of chronic treatment with L-arginine on atherosclerosis in apoE knockout and apoE/inducible NO synthase double-knockout mice.

Chen J, Kuhlencordt P, Urano F, Ichinose H, Astern J, Huang PL.

Arterioscler Thromb Vasc Biol. 2003 Jan 1;23(1):97-103.

3.

Physical inactivity increases oxidative stress, endothelial dysfunction, and atherosclerosis.

Laufs U, Wassmann S, Czech T, Münzel T, Eisenhauer M, Böhm M, Nickenig G.

Arterioscler Thromb Vasc Biol. 2005 Apr;25(4):809-14. Epub 2005 Feb 3.

4.

L-arginine and atherothrombosis.

Loscalzo J.

J Nutr. 2004 Oct;134(10 Suppl):2798S-2800S; discussion 2818S-2819S. Review.

5.

L-arginine increases plasma homocysteine in apoE-/-/iNOS-/- double knockout mice.

Handy DE, Scolaro J, Chen J, Huang P, Loscalzo J.

Cell Mol Biol (Noisy-le-grand). 2004 Dec;50(8):903-9.

PMID:
15704254
6.

Tetrahydrobiopterin: mediator of endothelial protection.

Katusic ZS, d'Uscio LV.

Arterioscler Thromb Vasc Biol. 2004 Mar;24(3):397-8. No abstract available.

7.

Antioxidants and the bioactivity of endothelium-derived nitric oxide.

Tomasian D, Keaney JF, Vita JA.

Cardiovasc Res. 2000 Aug 18;47(3):426-35. Review. No abstract available.

8.

Thrombin stimulates human endothelial arginase enzymatic activity via RhoA/ROCK pathway: implications for atherosclerotic endothelial dysfunction.

Ming XF, Barandier C, Viswambharan H, Kwak BR, Mach F, Mazzolai L, Hayoz D, Ruffieux J, Rusconi S, Montani JP, Yang Z.

Circulation. 2004 Dec 14;110(24):3708-14. Epub 2004 Nov 29.

9.

Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis.

Ignarro LJ, Napoli C.

Curr Diab Rep. 2005 Feb;5(1):17-23. Review.

PMID:
15663912
10.

Modulation of the nitric oxide synthase pathway in atherosclerosis.

Maxwell AJ, Tsao PS, Cooke JP.

Exp Physiol. 1998 Sep;83(5):573-84. Review. No abstract available.

11.

Dysfunction of endothelial nitric oxide synthase and atherosclerosis.

Kawashima S, Yokoyama M.

Arterioscler Thromb Vasc Biol. 2004 Jun;24(6):998-1005. Epub 2004 Mar 4. Review.

12.

[NO and atherosclerosis].

Ohtani K, Egashira K.

Nihon Rinsho. 2004 Sep;62 Suppl 9:544-7. Review. Japanese. No abstract available.

PMID:
15506446
13.

[Influence of L-arginine on development of atherosclerosis: what is the therapeutically assured?].

Bode-Böger SM.

Dtsch Med Wochenschr. 2005 Mar 18;130(11):593-8. Review. German.

PMID:
15761791
14.

Critical role of L-arginine in endothelial cell survival during oxidative stress.

Suschek CV, Schnorr O, Hemmrich K, Aust O, Klotz LO, Sies H, Kolb-Bachofen V.

Circulation. 2003 May 27;107(20):2607-14. Epub 2003 May 12.

15.
16.

Tetrahydrobiopterin: regulator of endothelial nitric oxide synthase in vascular disease.

Channon KM.

Trends Cardiovasc Med. 2004 Nov;14(8):323-7. Review.

PMID:
15596110
17.

Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis.

Ignarro LJ, Napoli C.

Curr Atheroscler Rep. 2004 Jul;6(4):281-7. Review.

PMID:
15191702
18.

Mechanisms of homocysteine-induced atherothrombosis.

Lentz SR.

J Thromb Haemost. 2005 Aug;3(8):1646-54. Review.

19.
20.

NOS inhibition accelerates atherogenesis: reversal by exercise.

Niebauer J, Maxwell AJ, Lin PS, Wang D, Tsao PS, Cooke JP.

Am J Physiol Heart Circ Physiol. 2003 Aug;285(2):H535-40. Epub 2003 Feb 21.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk